Shares of American Well Corporation (NYSE:AMWL – Get Free Report) have been assigned a consensus rating of “Hold” from the seven research firms that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and one has given a buy recommendation to the company. The average twelve-month target price among brokers that have issued ratings on the stock in the last year is $9.1667.
Separately, Wells Fargo & Company cut their price objective on American Well from $15.00 to $12.00 and set an “overweight” rating on the stock in a report on Thursday, August 7th.
Get American Well alerts:
View Our Latest Report on AMWL
American Well Trading Down 0.2%
Shares of American Well stock opened at $6.19 on Friday. The firm’s 50 day simple moving average is $7.11 and its two-hundred day simple moving average is $7.32. The firm has a market capitalization of $99.89 million, a price-to-earnings ratio of -0.77 and a beta of 1.27. American Well has a 12-month low of $6.08 and a 12-month high of $12.95.
American Well (NYSE:AMWL – Get Free Report) last released its earnings results on Tuesday, August 5th. The company reported ($1.24) earnings per share (EPS) for the quarter, beating the consensus estimate of ($1.84) by $0.60. The firm had revenue of $70.90 million for the quarter, compared to the consensus estimate of $63.87 million. American Well had a negative return on equity of 41.99% and a negative net margin of 46.15%. American Well has set its Q3 2025 guidance at EPS. FY 2025 guidance at EPS. On average, sell-side analysts predict that American Well will post -9.34 EPS for the current fiscal year.
Insider Buying and Selling
In other American Well news, insider Dmitry Zamansky sold 25,605 shares of the firm’s stock in a transaction that occurred on Wednesday, September 3rd. The shares were sold at an average price of $6.77, for a total transaction of $173,345.85. Following the completion of the transaction, the insider directly owned 197,711 shares of the company’s stock, valued at approximately $1,338,503.47. This trade represents a 11.47% decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Deborah C. Jackson sold 4,531 shares of American Well stock in a transaction that occurred on Monday, September 15th. The shares were sold at an average price of $6.56, for a total transaction of $29,723.36. Following the sale, the director owned 39,132 shares of the company’s stock, valued at approximately $256,705.92. The trade was a 10.38% decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last quarter, insiders have sold 44,092 shares of company stock worth $299,186. 12.80% of the stock is owned by company insiders.
Hedge Funds Weigh In On American Well
A number of institutional investors have recently modified their holdings of AMWL. Northern Trust Corp boosted its stake in shares of American Well by 7.4% in the fourth quarter. Northern Trust Corp now owns 29,021 shares of the company’s stock worth $210,000 after buying an additional 1,992 shares during the last quarter. Jane Street Group LLC lifted its holdings in American Well by 21.9% in the fourth quarter. Jane Street Group LLC now owns 19,260 shares of the company’s stock valued at $140,000 after acquiring an additional 3,462 shares during the period. Two Sigma Advisers LP lifted its holdings in American Well by 102.7% in the fourth quarter. Two Sigma Advisers LP now owns 41,045 shares of the company’s stock valued at $298,000 after acquiring an additional 20,800 shares during the period. Two Sigma Investments LP boosted its position in American Well by 12.3% in the 4th quarter. Two Sigma Investments LP now owns 19,216 shares of the company’s stock worth $139,000 after purchasing an additional 2,102 shares in the last quarter. Finally, Sapient Capital LLC acquired a new stake in shares of American Well during the 1st quarter worth approximately $79,000. Hedge funds and other institutional investors own 56.05% of the company’s stock.
About American Well
(Get Free Report)
American Well Corporation, an enterprise platform and software company, delivers digitally enabling hybrid care in the United States and internationally. The company offers Converge, a cloud-based platform that enables health providers, payers, and innovators to provide in-person, virtual and automated care; and delivers virtual primary care, post-discharge follow-up, chronic condition management, virtual nursing, e-sitting, on-demand and scheduled virtual visits, specialty consults, automated care, and behavioral health, as well as specialty care programs, including dermatology, musculoskeletal care, second opinion, and cardiometabolic care to patients and members.
Read More
Five stocks we like better than American Well
Low PE Growth Stocks: Unlocking Investment Opportunities
Tesla Earnings Loom: Bulls Eye $600, Bears Warn of $300
Best Energy Stocks – Energy Stocks to Buy Now
Cathie Wood Buys Alibaba and Baidu: Momentum or More Value Ahead?
What is the S&P 500 and How It is Distinct from Other Indexes
This ETF Weeds Out Small-Cap Underperformers